Subclinical ketosis in lactating dairy cattle.

Subclinical ketosis is an important and common condition of early-lactation dairy cattle. It is associated with losses in milk production and increased risk of periparturient disease. Prevention depends on several factors, including proper transition-cow nutrition, management of body condition, and the use of certain feed additives such as niacin, propylene glycol, and ionophores. All currently available cowside tests for subclinical ketosis have certain limitations in their use. Effective monitoring schemes for subclinical ketosis can be developed, however, and these may be useful in many herd health programs.     

Evaluation of two cowside tests for the detection of subclinical ketosis in dairy cows.

The goal of this study was to evaluate the sensitivity and specificity of two cowside tests for subclinical ketosis in dairy cows. The tests utilize milk and urine samples, respectively. One hundred and eighty-five cows, one to sixty days postpartum, were sampled for milk, urine, and blood. Subclinical ketosis was defined with serum beta-hydroxybutyrate measurements. The sensitivity and the specificity of both tests at different beta-hydroxybutyrate levels were estimated. When subclinical ketosis was defined at beta-hydroxybutyrate levels of 1.4 mmol/L and higher, the milk test had sensitivity of 90% and specificity of 96%. The urine test lacked specificity (values < 67%), but sensitivity was 100% at beta-hydroxybutyrate levels of 1.4 mmol/L upward. Both the milk and urine test can be used to monitor subclinical ketosis in a herd. Milk testing is preferred, because of the easy obtainability of milk combined with the overall better test characteristics.     

Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle

The effect of an autogenous vaccine against Staphylococcus aureus on S. aureus prevalence and mastitis, as well as on somatic cell count (SCC), was studied in a dairy herd with a high prevalence of S. aureus. The vaccination group (n = 35; 22 cows and 13 heifers) and the control group (n = 36; 23 cows and 13 heifers) received the vaccine or a placebo, respectively, according to the following protocol: all animals: basic immunization (twice, 3 weeks apart); cows: booster dose at the time of drying off, 5 and 2 weeks before calculated calving date; heifers: booster dose 2 and 5 weeks before calculated calving date. The vaccine or the placebo was administered subcutaneously in the area of the supramammary lymph nodes. Quarter milk samples were collected monthly and subjected to SCC and bacteriological evaluation. At this time, the animals were also checked for signs of clinical mastitis. Non-clinical S. aureus mastitis diagnoses were based on udder quarter SCC and a positive S. aureus culture. In order to compare the SCC in individual whole milk samples, records from the monthly milk quality testing were evaluated. Cow and udder quarter prevalence of S. aureus intramammary infections calculated for the experimental animals and quarters, respectively, did not differ between groups. However, during the lactation period following the boostcr dose, the prevalence of S. aureus increased in both groups (P < 0.05). The cumulative incidence of various mastitis diagnoses (clinical, subclinical, latent infection) due to S. aureus on an animal basis did not differ between groups. On an udder quarter basis, the cumulative incidence of subclinical mastitis was higher in vaccinated animals than in control animals (33.8 versus 26.0%; P < 0.05). This was mainly due to a higher cumulative incidence of subclinical mastitis in vaccinated than control heifers. The SCC in composite milk samples did not differ between groups, but increased as lactation progressed. The herd prevalence of S. aureus differed considerably throughout the study period, but declined consistently to below 10% at the end of the study period. Recent herd checks revealed a prevalence of S aureus infections of < 5%. It is concluded that the autogenous bacterin tested in this study did not have the desired effect on the prevalence of S. aureus infections and mastitis or SCC. The decline in S. aureus prevalence was very probably due to other factors than specific immunization against S. aureus.     

Risk Indicators Associated with Subclinical Mastitis in Smallholder Dairy Cows in Tanzania

Smallholder dairy farmers in Tanzania appear to be unaware of the subclinical mastitis situation in their cows. A cross-sectional study was carried out between June and September 2002 on smallholder dairy herds in the Dar es Salaam region. The study objectives were to establish the prevalence of subclinical mastitis and related risk indicators, and to assess their contribution to the occurrence of subclinical mastitis. Three field procedures based on the principles of herd health and production management were followed: clinical, farm and data inspection. The California mastitis test (CMT) was carried out on quarter milk samples to determine the prevalence of subclinical mastitis. A total of 182 lactating cows from 62 herds were investigated. Clinical inspection indicated that 3.8% of the lactating cows had clinical mastitis. Subclinical mastitis was detected in 90.3% of lactating cows screened. Farm inspection revealed that water scarcity, barn size, residual suckling, single udder-towel and dairy labourers as the most substantial (p < 0.05) risk indicators. Although most of the risk indicators studied were not found to be statistically significantly associated with the occurrence of subclinical mastitis, possibly owing to sample size and the presence of confounders, the epidemiological need to address such risk indicators cannot be overemphasized.     

Disease, production and culling in Holstein-Friesian cows: IV. Effects of disease on production

The effects of common clinical and two subclinical disease conditions (mastitis and ketosis) on milk production and reproductive performance in Holstein-Friesian cows were investigated in a two and a half year study. The data used were from 1315 lactation records and results from tests performed on 6241 composite milk samples.

Path analyses were used to estimate the direct and indirect impact of disease on days to conception, milk production in a standard 305 day lactation and milk production per day. Indirect effects accounted for a large percentage of the total effect of some diseases on production. The path coefficients were quite sensitive to the units used to measure production, with deviation from the herd average being the preferable measure. These units controlled confounding due to herd level variables. Effects identified by the path analyses were substantially different from those determined on the basis of unconditional associations between diseases and production parameters.

Subclinical mastitis and the reproductive diseases (most of which were subclinical in nature) were found to have the greatest detrimental impact on milk production per day. Several disease conditions had a beneficial effect on milk production and this was attributed to the therapy provided to cows affected with these conditions. All conditions related to reproductive performance had a detrimental effect on days to conception.     

Subclinical ketosis in dairy cows

Subclinical ketosis is defined as a preclinical stage of ketosis. The peak prevalence of subclinical ketosis occurs during the fourth week of lactation. Herd-related factors, breed, parity, and season are other important determinants. Subclinical ketosis can be revealed by determining levels of plasma glucose, plasma NEFA and blood, and milk or urine ketone body concentration. There are theoretical and practical advantages of using milk ketone bodies. Most authors are agreed on approximate lower and upper borderlines for subclinical ketosis. The risk of an outbreak of clinical symptoms has been evaluated by some authors. Most authors have found significant negative relationships between energy balance and ketone body concentration. Some disagreement may be attributable to the fact that the diets used in different experiments can have different glucogenic potential, even if the energy content is the same. This affects the relationship between energy balance and ketone body concentration, as the ketone body level is influenced by both the energy balance and plasma glucose. Feeding silage with high butyric acid content increases the risk of subclinical ketosis. There are indications that cows with the highest milk yield directly after calving are at greatest risk for developing ketosis. Increased ketone body level secondarily reduces milk production, a decrease that has been quantified by some authors. Subclinical ketosis causes delayed reproductive functions return to normal after calving, increased intervals from calving to first and last service, and an increased frequency of ovarian cysts. The routine determination of milk acetone levels in control programs can be used to evaluate the status of individual cows, to indicate the energy feeding in early lactation at a herd level, and to evaluate sires for breeding. The heritability and the tendency toward a positive genetic correlation between milk acetone and milk yield have also been discussed, as have aspects of nutritional prevention. Factors such as energy- and protein-rich roughage, tasty high-energy concentrates, suitable feeding during the dry period, and division of the concentrates into at least four meals are considered to be important.     

张家口地区奶牛隐性乳腺炎的流行特点

在春夏秋冬四个不同的季节采集张家口地区奶牛的奶样,通过CMT法检测奶牛隐性乳腺炎的发病率。结果个体阳性平均率为52.3%,阳性乳区平均率为19.2%,奶牛隐性乳腺炎的发病率与季节没有明显的相关性、与胎次呈正相关,后乳区的阳性率明显高于前乳区。     

规模化奶牛场奶牛亚临床型乳房炎流行规律调查

目的 本研究旨在摸清兰考县规模化奶牛场奶牛亚临床乳房炎流行规律,为该病的防控提供参考。方法 采用加州奶牛亚临床乳房炎试验（CMT）方法对3 家规模化奶牛场的547 头泌乳奶牛进行亚临床乳房炎检测,调查该病与奶牛胎次、泌乳期和乳区的关系。结果 奶牛阳性率为20.11%,乳区阳性率为10.88%;1~2、3~4和≥5胎次的奶牛发病率分别为13.37%、20.53%和29.46%;泌乳前期、泌乳中期和泌乳后期发病率分别为15.11%、22.12%和30.89%;乳区阳性率介于8.59%~13.16%。结论 兰考县规模化奶牛场奶牛亚临床型乳房炎的发病率相对较低,与胎次、泌乳期存在正相关,与乳区无明显关系。     

The Association Between Disease, Production and Culling in a University Dairy Herd

The impact of ten diseases of dairy cattle on milk production, calving interval and culling were studied in a university operated dairy herd. Cows with clinical mastitis, ketosis or displaced abomasum had lowered milk production. Cows with metritis, retained placenta, cystic graafian follicles or ovarian hypofunction had longer calving intervals. Cows with clinical mastitis, metritis, pneumonia or retained placenta had increased risks of culling.The relationship between disease and culling was based on the medical history of culled and nonculled cows using a case control approach. Therefore, it is likely that in many cases, the association between disease and culling is due to the impact of that disease on productivity.     

Subclinical ketosis: prevalence and associations with production and disease.

Cows in 32 southern Ontario Holstein herds were monitored for subclinical ketosis for a period of two and one half years. Milk samples were routinely collected and the level of milk ketone bodies determined by the use of a commercial nitroprusside based test powder (reactions scored as negative, +1 or +2). Approximately 92% of positive reactions were observed in the first 65 days of lactation and for that time period the prevalence of ketosis was 12.1%. Based on this prevalence, the minimum possible duration of subclinical ketosis would be 7.9 days and the minimum possible lactational incidence rate would be 12.1%. The prevalence during the first 65 days of lactation in individual herds ranged from 0 to 33.9%. Subclinical ketosis was more likely to be found in cows experiencing metritis than in unaffected cows. Detection of elevated levels of milk ketones also indicated that the cow had a significantly higher risk of having clinical ketosis, metritis or cystic ovaries diagnosed within the following four days. Milk ketone scores of +1 and +2 were found to be associated with a reduction in daily milk production of 1.0 and 1.4 kg of milk respectively.     

Field trial of a staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessments

Objective To assess the efficacy of a new staphylococcal mastitis vaccine under commercial dairying conditions.
Design A field trial involving 1819 cows and heifers conducted on seven dairy herds in Victoria. The trial was done 'blind'; approximately half the animals were vaccinated and the remainder were untreated controls.
Procedure The vaccine was given twice during the last 10 weeks of pregnancy. Effects of vaccination were assessed, during the ensuing lactation, on the basis of clinical and sub-clinical mastitis and microbiological investigations of the milk.
Results A total of 273 cases of clinical mastitis were recorded. Staphylococcus aureus was isolated from 112 of these, 45 cases in vaccinates and 67 cases in controls; the difference was not statistically significant. One herd was notable in having a high incidence of clinical staphylococcal mastitis. This herd accounted for 15.8% of the animals in the field trial but 54.5% of cases of clinical staphylococcal mastitis. For this herd, vaccinated animals had significantly lower incidence of clinical staphylococcal mastitis and prevalence of subclinical mastitis, relative to controls. An unexpected feature of the trial as a whole was the low incidence of clinical mastitis from which S aureus was isolated in pure culture (26.3% of cases) and the high incidence of clinical Streptococcus uberis mastitis (22.7% of cases).
Conclusions The trial showed that the vaccine was efficacious in reducing the incidence of clinical mastitis and prevalence of subclinical mastitis in a herd that had a serious staphylococcal mastitis problem.     

Disease, production and culling in Holstein-Friesian cows I. The data

A two-and-a-half-year study was undertaken in 32 commercial dairy herds within a 50-mile radius of Guelph, Ontario, in order to provide a comprehensive evaluation of relationships amongst diseases, production parameters and risk of removal in Holstein-Friesian cows. Diseases consisted of common clinical diseases as well as two subclinical diseases (mastitis and ketosis).

The data set consisted of a total of 2875 lactation records from 2008 cows. The means and standard deviations of some of the production parameters were: age 4.9 ± 2.5 year, breed class average for milk 140 ± 26 BCM units, milk production per day of life 18.0 ± 3.8 kg and days to conception 118 ± 60 days. Lactational incidence rates of the more common diseases were: reproductive tract infections 0.182, mastitis 0.168, cystic ovaries 0.104, subclinical ketosis 0.096, retained placenta 0.086 and ketosis 0.074. The average lactation mean log somatic cell count was 179 000 cells/ml. The times postpartum to the first diagnosis of all disease conditions are presented.     

Milk fever and subclinical hypocalcaemia--an evaluation of parameters on incidence risk, diagnosis, risk factors and biological effects as input for a decision support system for disease control.

The present review analyses the documentation on incidence, diagnosis, risk factors and effects of milk fever and subclinical hypocalcaemia. It is hereby evaluated whether the existing documentation seems sufficient for further modelling in a decision support system for selection of a control strategy. Several studies have been carried out revealing an incidence of milk fever most often in the level of 5-10%. Few studies indicate that the incidence of subclinical hypocalcaemia is several times higher than milk fever. The diagnosis based on clinical or laboratory methods or based on presence of risk factors is outlined. The clinical symptoms of milk fever are highly specific and the disease level may thus be determined from recording of treatments. Diagnosis of subclinical hypocalcaemia needs to include laboratory examinations or it may be determined by multiplying the incidence of milk fever by a certain factor. From the documentation on risk factors, it is very complex to predict the incidence from the exposure level of the risk factors. Due to uncertainty, sensitivity analyses over a wide range of values for each parameter are needed. The documentation of cow characteristics, nutrition, environment and management as risk factors are described. Among cow characteristics, parity or age, body condition and production level were found to be important. Risk factors associated with nutrition included most importantly dietary cation-anion difference and calcium level whereas the importance of general feeding related factors like type of feed stuff and feeding level were less clear. Environment and management included season, climate, housing, pasturing, exercise, length of dry period and prepartum milking. Several of the parameters on environment and management were confounded among each other and therefore firm conclusions on the importance were difficult. The documentation of the effect of milk fever includes the downer cows, reproductive disorders, occurrence of other diseases and the effect on milk production, body weight and culling. The reproductive disorders included most importantly dystocia, uterine prolapse, retained placenta, metritis and repeat breeding, and occurrence of other diseases included ketosis, displaced abomasum and mastitis. The documentation was substantial and often quantifiable within certain limits. Overall it is concluded that the present documentation on milk fever concerning incidence, diagnosis, risk factors and effects seems sufficient for a systematic inclusion in a decision support system. A model on milk fever should take into consideration the variation in biological data and individual herd characteristics. The inclusion of subclinical hypocalcaemia would be more uncertain and probably should await further documentation on possibilities of determining the herd level incidence and also the effect of this condition on production.     

Association between Coxiella burnetii shedding in milk and subclinical mastitis in dairy cattle

The objective of this research was to explore the potential association between Coxiella burnetii shedding in milk and chronic subclinical mastitis in dairy cattle. In two separate studies, we identified an association between PCR-based detection of C. burnetii in milk and chronic subclinical mastitis in lactating dairy cows. These studies were conducted in a commercial dairy herd where there was ongoing intensive monitoring of subclinical mastitis by aerobic bacteriology, but no prior knowledge or management of C. burnetii infections. In a case-control study, quarter level C. burnetii status determined by real-time quantitative PCR (RT-qPCR) was strongly associated with chronic subclinical mastitis as measured by milk somatic cell counts. In a subsequent cross sectional study, 147 (45%) of 325 lactating cows were positive for C. burnetii by RT-qPCR of composite milk samples. In a generalized linear model, accounting for the effect of covariates including aerobic intramammary infection status, C. burnetii PCR status was a significant predictor of linear somatic cell count score. In agreement with a small number of previous reports, this research provides evidence that there may be mammary gland specific manifestations of C. burnetii infections in dairy cattle.     

An epidemiologic study of disease in 32 registered Holstein dairy herds in British Columbia.

Data recorded in a herd health management system were obtained from 32 registered Holstein dairy herds from British Columbia. Frequencies of disease were described, and the effect of herd, age, year, season, and the interrelationships between diseases within a lactation on the occurrence of disease were evaluated. Lactational incidence rates were computed for diseases with a short period of risk (ie, udder edema, milk fever, retained placenta, metritis, displaced abomasum, and ketosis), whereas for diseases with a longer period of risk (ie, cystic ovaries, mastitis and stable footrot), incidence densities were calculated. Overall, the disease incidence was low and showed an increase in frequency by year, which we attributed to more observing and complete recording by the owner, rather than an actual increase in disease incidence. Most diseases occurred early in lactation and their frequency increased with lactation number; the exception was udder edema, which occurred mainly during the first 2 lactations. An informal path model of disease interrelationships was made conditional on herd. Based on the results we inferred 2 independent pathways: one started by udder edema, and the other by milk fever. Udder edema was directly associated with mastitis occurrence from 0 to 30 d in lactation, metritis, and cystic ovaries. Mastitis from 0-30 d in lactation increased the risk of both mastitis from 31-150 d in lactation and cystic ovaries. Both of these increased the risk of late lactation mastitis. Milk fever was directly related with displaced abomasum, which increased the risk of footrot. In general, diseases that occurred in early lactation tended to increase the risk of other diseases later in lactation.     

Associations between health disorders of French dairy cows and early and late culling within the lactation

Data from an observational study, carried out during a 4.5 year period (1986–1990), were used to quantify the effects of health disorders on the risk of culling. The study population consisted of 47 commercial Holstein dairy herds from western France, comprising 4123 cows.

Logistic regression was used to assess the relationships between health disorders and early and late culling. Fourteen main health disorders with clinical signs and one subclinical disease were studied: abortion, periparturient accident, calving provided with assistance, digestive disorders, ketosis, locomotor disorders, mastitis, metritis, milk fever, cystic ovaries, respiratory disorders, retained placenta, teat injuries, non-traumatic udder disorders and status with respect to milk somatic cell count. Adjustments were made for year, month of calving, parity, breeding value for milk, best of the two first milk production records and reproductive performance. The possible effects of interactions among variables were also studied. The herd effect was taken into account using random effect models.

Non-traumatic udder disorders, teat injuries, milk fever and the occurrence of both ketosis and assistance at calving were significantly associated with an increased risk of being early culled (odds ratios (OR) ranging from 1.6 to 10.3). Early and late abortion, late metritis, poor peproductive performance, retained placenta, non-traumatic udder disorders within 45 days post-partum and mastitis occurring in the first 3 months of the lactation were positively associated with a late culling (OR ranging from 1.2 to 6.6). Cows with lower breeding value for milk and higher parities were high risk groups for culling. A lower level of milk production and occurrence of both reproductive disorders and poor reproductive performance were risk factors for late culling.     

The consequences of risk-based surveillance: Developing output-based standards for surveillance to demonstrate freedom from disease

Risk factors associated with high or low long-term incidence of displaced abomasum (DA) or clinical ketosis were studied in 60 Swedish dairy herds, using multivariable logistic regression modelling. Forty high-incidence herds were included as cases and 20 low-incidence herds as controls. Incidence rates were calculated based on veterinary records of clinical diagnoses. During the 3-year period preceding the herd classification, herds with a high incidence had a disease incidence of DA or clinical ketosis above the 3rd quartile in a national database for disease recordings. Control herds had no cows with DA or clinical ketosis. All herds were visited during the housing period and herdsmen were interviewed about management routines, housing, feeding, milk yield, and herd health. Target groups were heifers in late gestation, dry cows, and cows in early lactation. Univariable logistic regression was used to screen for factors associated with being a high-incidence herd. A multivariable logistic regression model was built using stepwise regression. A higher maximum daily milk yield in multiparous cows and a large herd size (p = 0.054 and p = 0.066, respectively) tended to be associated with being a high-incidence herd. Not cleaning the heifer feeding platform daily increased the odds of having a high-incidence herd twelvefold (p < 0.01). Keeping cows in only one group in the dry period increased the odds of having a high incidence herd eightfold (p = 0.03). Herd size was confounded with housing system. Housing system was therefore added to the final logistic regression model. In conclusion, a large herd size, a high maximum daily milk yield, keeping dry cows in one group, and not cleaning the feeding platform daily appear to be important risk factors for a high incidence of DA or clinical ketosis in Swedish dairy herds. These results confirm the importance of housing, management and feeding in the prevention of metabolic disorders in dairy cows around parturition and in early lactation.     

Management factors associated with the incidence of clinical mastitis over the non-lactation period and bulk tank somatic cell count during the subsequent lactation

Aim: To evaluate associations between management decisions related to the control of mastitis, including the infusion of antibiotics at the end of lactation (dry-cow therapy; DCT), on the incidence of clinical mastitis over the non-lactating period and the bulk tank somatic cell count (BTSCC) in the subsequent lactation. Methods: Dairy herd owners (n=158) provided information via a retrospective survey about (a) the proportion of their herds treated with DCT; (b) DCT management, including: number of occasions on which cows were dried off; manipulation of feed and water intake around drying off; infusion technique (partial vs full depth insertion of cannula); and hygiene before and after DCT infusion; (c) occurrence of mastitis and frequency of occurrence following drying off and in the subsequent lactation; (d) number of cows culled for mastitis-related conditions; (e) reasons for culling; (f) incidence of clinical mastitis; and (g) stock purchase policy with regard to mastitis. The BTSCC for each vat of milk supplied for the 1999/2000 and 2000/2001 seasons, and records of antibiotic purchases were collated for each herd. The probability that >2% of cows within a herd were diagnosed with clinical mastitis over the dry period was initially examined using univariate analysis (i.e. chi2 or logistic regression) and associated factors (p<0.2) were offered to a reverse stepwise logistic regression model. Factors hypothesised as being associated with the average lactation log10 BTSCC for the 2000/2001 season were initially examined using univariate analysis (i.e. ANOVA or linear regression analysis) and associated factors (p<0.2) were then tested using a forward manual model-building approach. Results: Increasing the percentage of the herd treated with DCT at the end of lactation was associated with reduced probability that >2% of a herd would be diagnosed with clinical mastitis over the non-lactating period and with a lower BTSCC in the subsequent lactation (p<0.01). A lower BTSCC was associated with small herds (<150 cows; p<0.05), not reducing feed intake around drying off (p<0.05), checking for clinical mastitis over the dry period in the milking parlour rather than at pasture (p<0.05), partial insertion of the DCT cannula (p<0.01), and use of 'change in udder shape' during lactation as a diagnostic criterion for mastitis (p<0.05). The incidence of clinical mastitis over the dry period was positively associated with reduced feeding around drying off (p=0.05) and the estimated volume of milk being produced at the time of drying off (p=0.014). Conclusions: Use of dry cow therapy was associated with fewer cases of clinical mastitis over the non-lactating period and reduced BTSCC over the subsequent lactation. Reduced BTSCC was also associated with smaller herds, use of partial (compared with full depth) insertion of the DCT cannula, not reducing feed intake at the time of drying off, checking for clinical mastitis over the dry (non-lactation) period in the milking parlour, and use of udder shape for diagnosis during lactation. Control of clinical mastitis and BTSCC involves a range of management practices that need to be used in conjunction with DCT. Keywords: Dairy cows, mastitis, dry-cow therapy, somatic cell count, management practices.     

Studies on the incidence of clinical mastitis and blood levels of vitamin E and selenium in dairy herds in England

In a trial conducted in the south of England in January to February 1989, blood samples were obtained from nine dairy herds with more than 30 cases of clinical mastitis/100 cows and from nine herds with less than 30 cases/100 cows during the previous 12 months. Whole blood glutathione peroxidase (GSHPx) activity and plasma vitamin E concentration were determined for 12 cows in each herd. The mean (+/-sd) values for the herds with the lower incidence of mastitis were 7.57 +/- 1.86 micrograms/ml plasma vitamin E and 23.8 +/- 22.8 U/ml rbc GSHPx activity, compared with 7.74 +/- 1.69 micrograms/ml plasma vitamin E and 20.61 +/- 8.8 U/ml rbc GSHPx activity for the herds with the higher incidence of the disease. These values indicate that the vitamin E levels were generally adequate but that some animals and herds had low GSHPx activities, suggesting that their diets may have contained inadequate selenium. The activities of GSHPx and the vitamin E levels in plasma were not significantly different in the two groups of herds, and no relationship was found between the two nutrients and the incidence of clinical mastitis. However, there was a significant negative correlation between the activity of GSHPx and the bulk milk cell counts in the herds with a low incidence of mastitis suggesting that there was an association between the incidence of subclinical mastitis or inflammation and the selenium status of these herds.     

N-acetyl-beta-D-glucosaminidase as a predictor of milk loss and recovery after clinical mastitis

Milk samples were collected at onset of 508 episodes of clinical mastitis on a 1,700-cow dairy farm in Michigan. Daily milk production and disease events were recorded for all cows in the herd. Despite statistical association with severity of mastitis, this association was too weak for N-acetyl-beta-D-glucosaminidase (NAGase) activity to be of great value as a prognostic test for clinical mastitis. High milk NAGase activity was significantly (P less than 0.0001) associated with: increased duration of treatment; increased duration of clinical signs of mastitis; decreased daily milk production; and increased risk of the cow being culled because of mastitis. The NAGase value was combined with days in milk production, baseline milk production before mastitis onset, parity, and season of onset to predict the outcome of clinical cases as measured by the first 3 aforementioned variables. Statistical models explained little of the variability among cows in duration of treatment (R2 = 0.11), duration of clinical signs of infection (R2 = 0.11), and milk production change (R2 = 0.09).